Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway

The use of cisplatin as a chemotherapeutic drug is impeded by the development of drug resistance. Combination therapies of a chemosensitizer for cisplatin have been studied, but with little success, and the search for an effective combination therapy is continuing. Our earlier reports have shown tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Thangjam Davis, Singh, Ningthoujam Indrajit, Devi, Khuraijam Mrinalini, Meiguilungpou, Remmei, Khongsai, Lhaineichong, Singh, Lisam Shanjukumar, Bal, Naresh Chandra, Swapana, Ningombam, Singh, Chingakham Brajakishor, Singh, Thiyam Ramsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654912/
https://www.ncbi.nlm.nih.gov/pubmed/36364114
http://dx.doi.org/10.3390/molecules27217288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654912/
https://www.ncbi.nlm.nih.gov/pubmed/36364114
http://dx.doi.org/10.3390/molecules27217288

Ejemplares similares